Use of pharmacokinetic-pharmacodynamic modeling with Monte Carlo simulation to reduce antibiotic expenditures without compromising predicted efficacy

被引：0
|
作者：
Frei, CR
Lewis, JS
Burgess, DS
机构：
[1] Univ Texas, Austin, TX 78712 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Univ Hlth Syst, San Antonio, TX USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64798-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A160 / A160
页数：1
相关论文
共 23 条
  • [11] Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
    Zhong, Jiaojiao
    Le, Wenjing
    Li, Xuechun
    Su, Xiaohong
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [12] Pharmacokinetic-pharmacodynamic analysis of cefmetazole against extended-spectrum β-lactamase-producing Enterobacteriaceae in dogs using Monte Carlo Simulation
    Kusumoto, Mizuki
    Motegi, Tomoki
    Uno, Haruna
    Yokono, Mizuki
    Harada, Kazuki
    [J]. FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [13] USE OF MONTE CARLO SIMULATION (MCS) TO EVALUATE TOXICITY AND EFFICACY BREAKPOINTS OF A NOVEL ANTIBIOTIC
    Harigaya, Y.
    Chiswell, K. E.
    Hoover, J. L.
    Fossler, M. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S29 - S29
  • [14] Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
    Lodise, TP
    Lomaestro, B
    Rodvold, KA
    Danziger, LH
    Drusano, GL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4718 - 4724
  • [15] Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
    Song, Xiangqing
    Wu, Yi
    Cao, Lizhi
    Yao, Dunwu
    Long, Minghui
    [J]. FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [16] Pharmacokinetic-pharmacodynamic modeling and simulation to predict efficacy outcomes with eslicarbazepine acetate 800 mg once-daily as monotherapy for partial-onset seizures
    Sunkaraneni, Soujanya
    Passarell, Julie
    Ludwig, Elizabeth
    Pitner, Janet
    Grinnell, Todd
    Blum, David
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S117 - S117
  • [17] Rational dose selection for a nonnucleoside reverse transcriptase inhibitor through use of population pharmacokinetic modeling and Monte Carlo simulation
    Drusano, GL
    Moore, KHP
    Kleim, JP
    Prince, W
    Bye, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 913 - 916
  • [18] A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia
    Wei, Chuanqi
    Ni, Wentao
    Cai, Xuejiu
    Cui, Junchang
    [J]. INFECTIOUS DISEASES, 2015, 47 (12) : 846 - 851
  • [19] Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference
    Kimko, Holly
    Berry, Seth
    O'Kelly, Michael
    Mehrotra, Nitin
    Hutmacher, Matthew
    Sethuraman, Venkat
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (03) : 554 - 567
  • [20] Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle
    Wu, H.
    Baynes, R. E.
    Leavens, T.
    Tell, L. A.
    Riviere, J. E.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2013, 36 (03) : 248 - 257
123